PAP-S
50 was acquired from NZYTECH (Portugal) and 139 inserted into a pCMV plasmid from Clontech (USA).
140
Paraformaldehyde was purchased from Sigma-Aldrich. For amino acid analysis after addition of a known quantity of 198 α-aminobutyric acid as internal pattern, the polymer sample 199 was hydrolyzed (6 M HCl, 1% phenol, and 2.5 h at 155°C) 200 and evaporated. The powder was resuspended in 1 mL of 20 201 mM HCl and a 1/10 dissolution was prepared. The 202 quantification of the less represented amino acids was made 203 from the most concentrated sample and the quantification of 204 the most represented amino acids from the 1/10 dissolution. 205 For 1 H NMR, 10 mg of polymer was solved in 600 μL of 206 (CD 3 ) 2 SO. 207 2.3. Preparation and Nomenclature of ELR Com-208 plexes. To prepare the polyplexes, the ELR was dissolved in 209 ultrapure water to a concentration of 1 mg/mL, and they were 210 left at 4°C overnight. Complexes were formed in aqueous 211 solution by mixing the pDNA with the ELR solution in the 212 appropriate N/P ratios, where N corresponds to the number of 213 amine groups from the polymer and P to the phosphate groups 214 from the plasmid DNA. The mixtures were vortexed at 25°C 215 for 1 min and incubated at 25°C for 30 min for nanocomplex 216 formation. For experiments involving polyplexes and aptamers, 217 a solution of each aptamer (S2.2 or 5TR1) in ultrapure water 218 was added to the ELR/pDNA polyplex and the mixture left for 219 a further 30 min at room temperature. The complexes were 220 formed and designated according to the different N/P/Papt 221 ratios, where Papt corresponds to the number of phosphate 222 groups in the aptamers, maintaining the N/P ratio constant and 223 increasing Papt by adding more aptamer. 224 2.3.1. Formation of ELR−Aptamer Polyplexes Conjugated 225 with Au Nanoparticles. ELR polyplexes were formed as 226 described in section 2.3 at a 50/1/4 N/P/Papt ratio, although 227 in this case the 5′-thiol-modified 5TR1 aptamer was complexed 228 with the polyplex and incubated for 30 min at room 229 temperature. Gold nanoparticles (Sigma-Aldrich, USA) were 230 mixed with the polyplex solution to a final concentration of 5 231 nM and incubated for 5 min at room temperature. 232 2.4. Physical Characterization of ELR−pDNA Poly-233 plexes. 2.4.1. Calculation of T t for the ELR in the Presence of 234 pDNA. ELR−pDNA complexes were formed at three different 235 N/P ratios (5/1, 10/1, and 50/1). After complexation, the pH 236 was adjusted with NaOH 1 M or HCl 1 M, and dynamic light 237 scattering (DLS) measurements (Zetasizer NanoZs from 238 Malvern Instruments Ltd., UK) were performed at pH 5.0, 239 7.5, and 11.5 in the temperature range 30−65°C in order to 240 calculate the corresponding T t . 241 2.4.2. Gel Retardation Assay and pDNA Protection. The 242 ELR−pDNA complexes were prepared at different N/P ratios 243 (0.5, 1, 2, 3, 5, and 10/1). For the DNA protection experiment, 244 polyplexes and pDNA were additionally treated with the 245 restriction enzyme Dpn I (Thermo Scientific, USA) for 90 min. 246 All preparations were loaded onto a 0.8% agarose gel, and 247 electrophoresis was carried out in 1× TAE buffer at 60 mV for 248 120 min, staining with SimplySafe (EURx, Poland). The 249 complexed pDNA was visualized by exposure to UV light in a 250 transilluminator (Vilber, Germany). 251 2.4.3. Particle Size and Zeta Potential. The particle size and 252 zeta potential of the ELR/pDNA/aptamers at different ratios 253 were measured using the Zetasizer NanoZs at a temperature of 254 37°C. Z-average mean (nm) and zeta potential (mV) were 255 used for data analysis. Experiments were repeated three times. For these experiments, the polyplexes ELR−pDNA (N/P 364 50/1) and ELR−pDNA−aptamer (N/P/Papt 50/1/4) were 365 formed using the pCMV-PAP plasmid. Cells were incubated 366 with the nanocomplexes at 37°C, 5% CO 2 for 5 h. After this 367 time, the medium was replaced with fresh medium containing 368 10% FBS, and the cells incubated at 37°C, 5% CO 2 for a 369 further 43 h. Cell death was quantified using the LIVE/DEAD 370 assay following the manufacturer's instructions and measured at 371 an emission wavelength of 620 nm after excitation at 525 nm 372 using a SpectraMax M2 microplate reader (Molecular Devices, 373 USA). 374 2.7. Statistical Analysis. The RLU/mg in transfection of 375 ELR−pDNA polyplexes was analyzed using Student's t test. All 376 results with p < 0.05 for three independent experiments were 377 considered to be statistically significant. Figure S1 ).
RESULTS
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The overall results displayed a high purity polymer with suitable 389 chemical compositions ( Figure S1 ). The amino-acid analysis 390 showed an appropriate composition, and the differences can be 391 attributed to the experimental error of the technique. As 392 reflected in the MALDI-TOF spectrum, the experimental 393 molecular weight of the ELR was 32 314.1 Da (SD: ±1.7), 394 whereas the expected value was 32 368 Da. Additionally, the 395 production yield of the bioprocess was 90 mg/L cell culture 396 and the final endotoxin levels were less than 10 EU/mg, which 397 is adequate for in vitro transfection assays. 52, 53 In addition, the 398 T t of the ELR was assessed by DLS at different pH values. 60°C for all the pH tested. Figure S4 ). Additionally, nano-and 429 microaggregation process between polyplexes occurred. Fur-430 thermore, an increase in the N/P ratio from 5/1 to 50/1 also 431 resulted in an increase in T t (Figure 1) . Consequently, herein 432 we provide evidence that the ELR−pDNA polyplexes are stable 433 complexes at physiological conditions in all the ratios tested, 434 and they are not influenced by the smart behavior inherent to 435 ELRs, which is present at the highest pH. Similarly, there was a striking increase in PdI at the N/P/Papt Figure 2 . Size, polydispersity index (PdI), and zeta potential for the ELR−pDNA polyplexes. Size (A) and zeta potential (B) for ELR−pDNA polyplexes with an N/P ratio ranging from 2/1 to 50/1. Size (C) and zeta potential (D) for ELR−pDNA−aptamer complexes with an N/P/Papt ratio ranging from 5/1/0 to 5/1/4. Size (E) and zeta potential (F) for ELR−pDNA−aptamer complexes with an N/P/Papt ratio ranging from 50/1/ 0 to 50/1/49 (n = 3, mean ± SD). Additionally, a further study of polyplex surface charge was 459 performed using the zeta potential. The results of this study 460 showed a progressive increase in zeta potential from −23 mV 461 (N/P 2/1) to nearly +40 mV (N/P 10/1), with the value being 462 dependent on polymer concentration ( Figure 2B ). At N/P 463 ratio of 2/1 the polyplex exposes the negative charges from the 464 plasmid outward. At this low ratio, the positive charge from the 465 amine groups in the ELR seems to be strongly affected by the 466 presence of phosphate groups from the pDNA and the 467 hydrophobic environment derived from the ELR polymer 468 structure. A striking increase from negative to positive values 469 was observed on going from a ratio of 2/1 to 3/1, and 470 stabilization of the surface charge was observed from 10/1 to 471 50/1 ratio. However, the addition of higher aptamer 472 concentrations initially resulted in a slight decrease in the 473 zeta potential at the low N/P ratio of 5/1, with a marked drop 474 being observed at 5/1/2 ( Figure 2D ). In contrast, the behavior 475 of the high ratio polyplex (50/1) showed the formation of a 476 stable positively charged particle (+40 mV) up to a ratio 50/1/ 477 24, with a striking drop for the neutralization ratio 50/1/49 478 ( Figure 2F ). Figure 3A ) and presence 482 ( Figure 3B ,C) of aptamer 5TR1 adsorbed on the polyplex at an 483 N/P/Papt ratio of 50/1/4. As can be seen from these figures, 484 the 50/1 polyplexes possess a rounded shape with a size (123.8 485 nm ± 12.1 SD) that correlates with the values obtained by DLS 486 (134.1 nm ± 2.5 SD). The pDNA appears to be located inside 487 the polyplex with the polymer surrounding it, as can be seen 488 from the different density of the particle nucleus ( Figure 3A) . 489 Additionally, there appears to be no difference in the 490 morphology of these two kinds of polyplexes ( Figure 3A,B) . 491 A further study that showed the noncovalent absorption of the 492 aptamer to the polyplex surface was performed. To this end, 493 gold nanoparticles (5 nm) were mixed to a polyplex previously 494 made with a thiol-modified 5TR1 aptamer. The resulting 495 complexes ( Figure 3C ) possess a homogeneous shape and a 496 size in agreement with the TEM ( Figure 3B) and DLS values 497 ( Figure 2E ), indicating that the gold nanoparticles mainly cover The effect of both types of polyplexes was first studied using 544 MUC1+ cells in order to determine the best candidate. As f5 545 shown in Figure 5A , there were important differences in 546 luciferase expression in MCF-7 cells between the two ELR 547 polyplexes. Thus, in the absence of aptamers, the 50/1 polyplex 548 was found to be more efficient than the 5/1 ratio, exhibiting a 549 10-fold higher luciferase expression. However, the most marked 550 differences were observed after incorporation of the aptamers. 551 Thus, the use of different ratios of the two aptamers with the 5/ 552 1 polyplex had little effect on MCF-7 transfection, whereas the 553 incorporation of both oligonucleotides into the 50/1 polyplex 554 produced an aptamer-dependent amplification of its trans-555 fection efficiency. Five different aptamer concentrations were 556 used in the test, and in both cases, higher aptamer 557 concentrations resulted in lower transfection. At low ratios with aptamer (1.6 times). The highest decrease corresponded Figure 4 . Viability of MCF-7 and HepG2 cell lines at different N/P/ Papt ELR−pDNA ratios for aptamers S2.2 and 5TR1. Cells were coincubated with the polyplexes, and a viability assay was performed for all samples. Untreated cells were considered as 100% viability control and PEI polyplexes as a reference transfection system (n = 3 independent experiments, mean ± SD). *p < 0.05, **p < 0.01. 3.3.3. Cellular Uptake of Polyplexes. The intracellular 602 uptake of these ELR−pDNA−5TR1 polyplexes was confirmed 603 using various techniques. To this end, MCF-7 cells were 604 incubated with 50/1/4 polyplexes containing fluorescein-605 labeled pCMV-Gaussia Luciferase plasmid for 3 h, and the 606 resulting internalization process was initially visualized by f6 607 fluorescence microscopy ( Figure 6A) . Although a few 608 polyplexes were observed on the surface of the tissue culture 609 plaque, a broad distribution of nanoparticles associated with the 610 cells could also be seen. The labeled cells were then detached 611 with trypsin, in order to remove the external binding 612 fluorescence signal that could interfere with the detection of 613 the intracellular polyplexes, 57,58 washed with PBS and analyzed 614 by flow cytometry. The results were compared with cells 615 transfected using the fluorescent plasmid alone ( Figure 6B ). 616 The data showed a marked internalization of polyplexes of 617 85.76 ± 12.35% (mean ± SD) for all cells, in comparison with 618 cells treated with fluorescein-labeled pDNA alone (1.70 ± 619 1.68%). Finally, trypan blue treated cells were visualized by 620 confocal microscopy in a z-series succession explained in Figure  621 S8 where the two focal planes confirmed the presence of 622 polyplexes inside the cells (Figure 6C ,D) and the likely 623 presence of fluorescent plasmid inside the nucleus (indicated by 624 arrows). An additional visualization with the nucleus stained 625 with DAPI evidenced the presence of pDNA inside the nucleus 626 ( Figure S9 ).
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This group of assays demonstrated the cellular internalization 628 and nuclear localization of ELR−pDNA polyplexes equipped 629 with cell specificity provided by the MUC1-directed aptamers. pathways over the gene expression (Figure 7 ). 
DISCUSSION
691 A variety of strategies have been applied in order to design 692 biomaterials with application in gene therapy. Herein we report 693 the design of a specific gene-delivery system for breast cancer 694 based on ELR−pDNA polyplexes and complexed with MUC1-695 specific aptamers. The ELR used in this study was constructed 696 using recombinant techniques, thus giving them a high level of Polyplexes were incubated with cells after treatment with 25 μM of chloroquine, 1 μg/mL of filipin, 5 μg/mL of amiloride, and 100 μM of monodansylcadaverine. The results expressed as % of control are mean ± standard error of three independent experiments. *p < 0.05, **p < 0.01.
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Article 760 of 50/1/49 ratio), which is in accordance with the DLS results 761 ( Figures 2E and 3A,B) . The surface charge density studied as 762 zeta potential is directly related to the stability of many colloidal 763 systems, and it is thought that a positive zeta potential should 764 favor interaction with the cell membrane. 48 However, the 765 incorporation of aptamers that provide cell specificity may 766 decrease the surface charge of the polyplex. This hypothesis was 767 corroborated in the assays conducted in this work. Initially, the 768 location of the polymer on the periphery of the polyplex where 769 it exposes its positively charged ε-amino groups to the exterior 770 while maintaining a neutralized charge inside was shown from 771 N/P ratio of 3/1. The subsequent incorporation of increasing 772 amounts of aptamer resulted in a marked decrease in the 773 surface charge of the ELR−pDNA due to neutralization of the 774 system and a widespread distribution of the aptamers on the Figure 5B ). Initially, the specificity of the polyplex−aptamer 855 system was evaluated using the MUC1-HepG2, with significant to be internalized in a lower proportion by caveolin and Figure 9 . Targeted killing ability of ELR−PAP−5TR1 polyplexes. Percent dead cells was calculated by fluorescence quantification. Cells were preincubated for 5 h with minimum medium (untreated), pCMV-PAP plasmid alone (pDNA), ELR−pDNA (polyplex), and ELR−pDNA conjugated with aptamer 5TR1 (polyplex 5TR1). Additional incubation under standard conditions up to 48 h was then carried out. Mean ± standard error of three independent experiments. A statistical analysis showed significant differences (*p < 0.05, **p < 0.01). 
